MY159072A - Probiotics to increase iga secretion in infants born by caesarean section - Google Patents

Probiotics to increase iga secretion in infants born by caesarean section

Info

Publication number
MY159072A
MY159072A MYPI2011000214A MYPI2011000214A MY159072A MY 159072 A MY159072 A MY 159072A MY PI2011000214 A MYPI2011000214 A MY PI2011000214A MY PI2011000214 A MYPI2011000214 A MY PI2011000214A MY 159072 A MY159072 A MY 159072A
Authority
MY
Malaysia
Prior art keywords
probiotics
caesarean section
iga secretion
infants born
increase iga
Prior art date
Application number
MYPI2011000214A
Inventor
Florence Rochat
Marie-Claire Fichot
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39769543&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY159072(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MY159072A publication Critical patent/MY159072A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

USE OF PROBIOTIC BACTERIA IN THE MANUFACTURE OF A MEDICAMENT OR THERAPEUTIC NUTRITIONAL COMPOSITION FOR INCREASING IGA SECRETION IN AN INFANT DELIVERED BY CAESAREAN SECTION DURING THE FIRST FOUR MONTHS OF THE LIFE OF THE INFANT.
MYPI2011000214A 2008-07-21 2009-07-15 Probiotics to increase iga secretion in infants born by caesarean section MY159072A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08160806A EP2147678A1 (en) 2008-07-21 2008-07-21 Probiotics to increase IgA secretion in infants born by caesarean section

Publications (1)

Publication Number Publication Date
MY159072A true MY159072A (en) 2016-12-15

Family

ID=39769543

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2011000214A MY159072A (en) 2008-07-21 2009-07-15 Probiotics to increase iga secretion in infants born by caesarean section

Country Status (15)

Country Link
US (1) US9060540B2 (en)
EP (2) EP2147678A1 (en)
CN (1) CN102159226B (en)
AU (1) AU2009273331B2 (en)
BR (1) BRPI0916275A2 (en)
CA (1) CA2731541A1 (en)
CL (1) CL2011000146A1 (en)
ES (1) ES2442344T3 (en)
MX (1) MX2011000737A (en)
MY (1) MY159072A (en)
PL (1) PL2315595T3 (en)
PT (1) PT2315595E (en)
RU (1) RU2496505C2 (en)
WO (1) WO2010010021A1 (en)
ZA (1) ZA201101336B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9200091B2 (en) * 2010-07-12 2015-12-01 The Regents Of The University Of California Bovine milk oligosaccharides
PT2734049T (en) 2011-06-20 2018-07-24 Heinz Co Brands H J Llc PROBIOTIC COMPOSITIONS AND METHODS
EP2609814A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of cognitive function
EP2609813A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system
AU2012369298B2 (en) * 2012-02-10 2016-02-25 N.V. Nutricia Maternal supplement to enhance immune system of an infant
BR112015028164B1 (en) 2013-05-10 2022-02-08 H.J. Heinz Company Brands Llc USES OF THE PROBIOTIC BACTERIA, LACTOBACILLUS PARACASEI, TO TREAT A MICROBIAL INFECTION AND TO PREVENT OR REDUCE THE SEVERITY OF A MICROBIAL INFECTION
US20170000810A1 (en) * 2013-12-19 2017-01-05 Nestec S.A. Nutritional composition to reduce metabolic stress in infants
CN115349635A (en) 2014-01-10 2022-11-18 雀巢产品有限公司 Vitamin B6 administration to pregnant and lying-in women to prevent increased adiposity, overweight or obesity in the offspring
RU2016132886A (en) 2014-01-10 2018-02-14 Нестек С.А. INTRODUCTION OF VITAMIN B12 MOTHER FOR PREVENTION OF INCREASED OBESITY, OVERWEIGHT OR OBESITY IN CELEBRATION, ESPECIALLY IN CELEBRATION OF MOTHERS WITH OVERWEIGHT AND / OR OBESITY
US20170087161A1 (en) * 2014-03-21 2017-03-30 Nestec S.A. Maternal vitamin b2 administration for the prevention of increased adiposity, overweight or obesity in the offspring
WO2015177246A2 (en) * 2014-05-20 2015-11-26 Biogaia Ab Neonatal microbiome supplementation
CN104206539A (en) * 2014-08-14 2014-12-17 澳优乳业（中国）有限公司 Probiotic-containing infant milk powder
US11369646B2 (en) 2014-10-29 2022-06-28 Biogaia Ab Use of L. reuteri for recovery of microbiota dysbiosis in early life
WO2016183535A1 (en) * 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
CN107920579A (en) * 2015-08-04 2018-04-17 雀巢产品技术援助有限公司 The intestinal microbiota close with the intestinal microbiota of the infant of breast-feeding for induction includes bifidobacterium animalis acid subspecies（Bifidobacterium animalis ssp.lactis）And the alimentation composition and infant formula of the mixture of optional oligosaccharide
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN108697141A (en) * 2015-12-29 2018-10-23 N·V·努特里奇亚 Nutritional formula containing non-digestible oligosaccharides and non-replicating lactic acid producing bacteria
BR112018013501B1 (en) 2015-12-29 2022-12-20 N.V. Nutricia USE OF A FERMENTED INGREDIENT AND NON-DIGERABLE OLIGOSACCHARIDE
CA3030809A1 (en) 2016-07-28 2018-02-01 Fonterra Co-Operative Group Limited Sialyloligosaccharide product and process
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
EP3618843A1 (en) * 2017-05-05 2020-03-11 Société des Produits Nestlé S.A. Treatment of infant colic
WO2020063553A1 (en) * 2018-09-30 2020-04-02 内蒙古伊利实业集团股份有限公司 Bifidobacterium lactis bl-99 and application thereof
CN114540245B (en) * 2022-03-17 2023-11-28 江南大学 Lactobacillus rhamnosus CCFM1228 with depression emotion relieving and intestinal tract secretion IgA promoting functions and application thereof
CN114517171B (en) * 2022-03-17 2023-11-28 江南大学 A strain of Lactobacillus fermentum CCFM1225 that can promote intestinal secretion of IgA and its application
CN114540247B (en) * 2022-03-17 2023-11-28 江南大学 Lactobacillus fermentum CCFM1226 capable of improving intestinal IgA level and relieving enteritis and application thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
ES2124060T5 (en) 1992-07-06 2002-12-16 Nestle Sa LACTICAL BACTERIA.
ATE161181T1 (en) 1992-07-06 1998-01-15 Nestle Sa ANTIGASTRITIS AGENTS CONTAINING LACTOBACILLUS ACIDOPHILUS
FI104465B (en) 1995-06-14 2000-02-15 Valio Oy Protein hydrolyzates for the treatment and prevention of allergies and their preparation and use
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
AU2002951270A0 (en) * 2002-09-06 2002-09-19 Vri Biomedical Ltd Probiotic Bacterium and Methods of Use
WO2004112507A1 (en) * 2003-06-23 2004-12-29 Nestec S.A. Infant or follow-on formula
CN101151041B (en) * 2005-02-02 2012-12-05 株式会社明治 Composition for immune activation
AU2006233918B2 (en) * 2005-04-13 2012-06-21 Nestec S.A. Infant formula with probiotics
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
US9005682B2 (en) * 2006-03-07 2015-04-14 Nestec S.A. Synbiotic mixture
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota

Also Published As

Publication number Publication date
RU2011106319A (en) 2012-08-27
US20110129452A1 (en) 2011-06-02
ES2442344T3 (en) 2014-02-11
CN102159226B (en) 2014-02-26
US9060540B2 (en) 2015-06-23
PL2315595T3 (en) 2014-04-30
EP2315595A1 (en) 2011-05-04
RU2496505C2 (en) 2013-10-27
AU2009273331B2 (en) 2014-12-04
BRPI0916275A2 (en) 2015-11-10
CL2011000146A1 (en) 2011-06-17
AU2009273331A1 (en) 2010-01-28
CN102159226A (en) 2011-08-17
MX2011000737A (en) 2011-02-24
PT2315595E (en) 2013-11-25
ZA201101336B (en) 2012-07-25
WO2010010021A1 (en) 2010-01-28
CA2731541A1 (en) 2010-01-28
EP2315595B1 (en) 2013-11-06
EP2147678A1 (en) 2010-01-27

Similar Documents

Publication Publication Date Title
MX2009009931A (en) Probiotics to reduce development of allergy in infants born by caesarean section.
UA96984C2 (en) Reduction of risk diarrhoea
PH12014501749B1 (en) A nutritional composition comprising probiotics and improving sleep patterns
MY158816A (en) Probiotics for reduction of risk of obesity
PH12017500874A1 (en) Human milk oligosaccharides for modulating inflammation
NZ613165A (en) Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated fatty acids and uses thereof
MX2010005132A (en) Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates.
IN2012DN00878A (en)
MX2011012063A (en) Infant and young children feeding formula comprising probiotics for infants and young children.
MY169326A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MY196432A (en) Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
MY191538A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
PH12014500185A1 (en) Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MY182617A (en) Probiotic stabilization
MX347403B (en) Anti-regurgitation and/or anti-gastrooesophageal reflux composition, preparation and uses.
MX2010002978A (en) Nutritional formulation with high energy content.
MY146018A (en) Method for improved breast milk feeding to reduce the risk of allergy
UA33597U (en) Method for prevention and correction of disbiotic states in newborn infants, born in mothers with herpesvirus infection
TH144912A (en) Reducing the risk of developing diarrhea
PH12013501388A1 (en) Methods of using human milk oligosaccharides for improving airway respiratory health